Is HLNE a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Evergreen and private-wealth distribution, with revenue (ttm) at ~$858 million (June 2026 quarter ~$275 million). The bear case rests on the accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Analysts covering it are spread from $105.00 to $182.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $105.00, +0.7% from the $104.24 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Evergreen and private-wealth distribution. The evergreen platform passed $19 billion in AUM with roughly $640 million of net inflows in the June 2026 quarter, and it carries higher fee rates than the institutional separate-account book. The most optimistic analyst target on HLNE is $182.00, +74.6% from the $104.24 price. That figure is only reachable if this thesis works close to its best case.

The accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Second, incentive fees and carried interest depend on exits, so a prolonged slow market for private-markets realizations can flatten the most profitable revenue line for several quarters. Third, fundraising is episodic, and a specialized fund that raises below its predecessor shows up directly in fee-earning AUM. Fourth, the evergreen push depends on distribution partners who can reallocate shelf space to Blackstone, Apollo, Ares or Blue Owl at any time, and semi-liquid funds carry redemption risk if private marks fall. Finally, the roughly $914 billion advisory book is large but low-fee, and clients that build internal teams or renegotiate retainers can shrink it without any change in market conditions. The most pessimistic published target is $105.00, +0.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Private-markets allocator earning management and advisory fees on separate accounts, secondaries and co-investment funds, plus evergreen wealth products.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Evergreen and private-wealth distribution) stalling in the reported numbers rather than in the narrative, the risk above (the accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It allocates capital into private markets on behalf of institutions and, increasingly, individual investors. It picks and monitors private equity, private credit, secondaries, infrastructure and co-investment exposure through customized separate accounts, commingled specialized funds, and advisory mandates. It is not a buyout firm and generally does not control operating companies itself.

Mostly through management and advisory fees charged on fee-earning AUM, which was about $83.7 billion as of June 30, 2026 at a blended rate near 69 basis points on specialized funds. On top of that sit incentive fees and carried interest, which are far more variable because they depend on fund performance and, in the evergreen vehicles, on NAV appreciation. Technology and reporting services add a smaller recurring stream.

The $1.1 trillion figure is assets under management and supervision, and roughly $914 billion of it is non-discretionary advisory assets that Hamilton Lane reports on or advises against for flat or retainer-style fees. Only about $83.7 billion is fee-earning AUM in the sense that a percentage-of-assets management fee applies. Anyone valuing the stock on the trillion-dollar number will badly overstate the revenue base.